Evaluating the ASTHMAXcel Mobile Application Regarding Asthma Knowledge and Clinical Outcomes.

BACKGROUND: We sought to longitudinally assess the efficacy of the patient-facing ASTHMAXcel mobile application in improving asthma knowledge and outcomes in adults with asthma. METHODS: ASTHMAXcel is a novel smartphone application consistent with the National Asthma Education and Prevention Program...

Descripción completa

Detalles Bibliográficos
Publicado en:Respiratory Care Vol. 65; no. 8; pp. 1112 - 1120
Autores principales: Hsia, Brian C., Wu, Sammy, Mowrey, Wenzhu B., Jariwala, Sunit P.
Formato: pictorial research tables/charts Journal Article
Publicado: Mary Ann Liebert, Inc. Aug2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145118951&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 145118951
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00201324
        4GG
      jtl: Respiratory Care
      issn: 00201324
      maglogo: N
    pubinfo:
      dt: Aug2020
      vid: 65
      iid: 8
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        145118951
        145118951
        145118951
        10.4187/respcare.07550
        145118951
      ppf: 1112
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Evaluating the ASTHMAXcel Mobile Application Regarding Asthma Knowledge and Clinical Outcomes.
      aug:
        au:
          Hsia, Brian C.
          Wu, Sammy
          Mowrey, Wenzhu B.
          Jariwala, Sunit P.
        affil: Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York
      sug:
        subj:
          Mobile Applications Evaluation
          Asthma Prevention and Control
          Health Knowledge
          Patient Education
          Outcomes (Health Care)
          Human
          Questionnaires
          Office Visits
          Hospitalization
          Prednisone Therapeutic Use
          Time Factors
          Emergency Service
          Health Resource Utilization
          Funding Source
          Quality of Life
          Prospective Studies
          Male
          Female
          Interviews
          Descriptive Statistics
          Paired T-Tests
          Pearson's Correlation Coefficient
          Data Analysis Software
          Adult
          Middle Age
          Aged
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: BACKGROUND: We sought to longitudinally assess the efficacy of the patient-facing ASTHMAXcel mobile application in improving asthma knowledge and outcomes in adults with asthma. METHODS: ASTHMAXcel is a novel smartphone application consistent with the National Asthma Education and Prevention Program, Global Initiative for Asthma, and British Thoracic Society/Scottish Intercollegiate Guidelines Network guidelines. The intervention was provided for 1-time use at baseline only. The Asthma Knowledge Questionnaire (AKQ), the Asthma Control Test (ACT), and the mini-Asthma Quality of Life Questionnaire (mini-AQLQ) were administered at baseline and at 2, 4, and 6 months thereafter. Rates of asthma-related emergency department visits, hospitalizations, and prednisone use were also evaluated. RESULTS: ACT scores increased significantly at 2, 4, and 6 months (mean scores: 15.1 vs 16.9, P = .038; 15.1 vs 17.2, P = .02; 15.1 vs 17.9, P = .003) after baseline. There were significant increases in AKQ scores at 4 and 6 months (11.7 vs 12.6, P = .02; 11.7 vs 13.1, P = .005) and in mini-AQLQ scores at 6 months (55.5 vs 64.2, P = .02). There were significant decreases in asthma-related emergency department visits at 6 months (0.6 vs 0, P < .001) and in hospitalizations at 4 and 6 months (0.3 vs 0.1, P = .02; 0.3 vs 0, P = .002). Prednisone use decreased at 4 and 6 months (1.2 vs 0.6, P = .01; 1.2 vs 0.3, P < .001). CONCLUSIONS: ASTHMAXcel contributes to improved asthma knowledge and outcomes and to decreased health care utilization. ASTHMAXcel is an inexpensive, scalable aid for out-patient asthma management.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N